Literature DB >> 9039175

Chemotherapy for disseminated actinic keratoses with 5-fluorouracil and isotretinoin.

C A Sander1, C Pfeiffer, A M Kligman, G Plewig.   

Abstract

BACKGROUND: Disseminated actinic keratoses are a therapeutic problem.
OBJECTIVE: Our purpose was to evaluate the efficacy of a combination of topical 5-fluorouracil twice a day and 20 mg of oral isotretinoin daily for disseminated actinic keratoses.
METHODS: Twenty-seven patients who had disseminated actinic keratoses (3 women, 24 men) were treated with 5-fluorouracil (5%) twice a day applied to the photodamaged area bearing actinic keratoses along with oral isotretinoin, 20 mg daily. The median treatment time was 21 days.
RESULTS: Actinic keratoses disappeared and signs of photodamaged skin improved in all patients. Side effects were burning and itching as well as painful erosions during the final stage of treatment.
CONCLUSION: The combination of topical 5-fluorouracil and isotretinoin is highly effective in the treatment of disseminated actinic keratoses on photodamaged skin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9039175     DOI: 10.1016/s0190-9622(97)70287-1

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  9 in total

1.  Use of oral isotretinoin in the management of rosacea.

Authors:  Hyunhee Park; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2011-09

Review 2.  Updated Physician's Guide to the Off-label Uses of Oral Isotretinoin.

Authors:  Steven Brandon Nickle; Nathan Peterson; Michael Peterson
Journal:  J Clin Aesthet Dermatol       Date:  2014-04

Review 3.  [Actinic keratoses. Pathogenesis, clinical aspect and modern therapeutic options].

Authors:  T Strunk; R-M Szeimies
Journal:  Hautarzt       Date:  2014-03       Impact factor: 0.751

4.  [Centrifugal plaques with central atrophy and peripheral scale on the scalp].

Authors:  P Nenoff; T Arnold; H Nenning; W Hindermann
Journal:  Hautarzt       Date:  2011-07       Impact factor: 0.751

5.  Total body topical 5-fluorouracil for extensive non-melanoma skin cancer.

Authors:  Serge van Ruth; Frank G A Jansman; Cornelis J Sanders
Journal:  Pharm World Sci       Date:  2006-09-27

Review 6.  [Actinic keratoses].

Authors:  P Babilas; M Landthaler; R-M Szeimies
Journal:  Hautarzt       Date:  2003-06       Impact factor: 0.751

7.  Characterization and evaluation of 5-fluorouracil-loaded solid lipid nanoparticles prepared via a temperature-modulated solidification technique.

Authors:  Meghavi N Patel; Sushant Lakkadwala; Mohamed S Majrad; Elisha R Injeti; Steven M Gollmer; Zahoor A Shah; Sai Hanuman Sagar Boddu; Jerry Nesamony
Journal:  AAPS PharmSciTech       Date:  2014-07-18       Impact factor: 3.246

8.  [Topical therapy of squamous cell carcinoma].

Authors:  U R Hengge
Journal:  Hautarzt       Date:  2007-05       Impact factor: 0.751

9.  Oral isotretinoin for the treatment of dermatologic conditions other than acne: a systematic review and discussion of future directions.

Authors:  Sherman Chu; Lauren Michelle; Chloe Ekelem; Calvin T Sung; Nathan Rojek; Natasha A Mesinkovska
Journal:  Arch Dermatol Res       Date:  2020-11-05       Impact factor: 3.017

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.